Hi IronPig. I don’t disagree with your thinking with regards...

First 377 Last

Share
Profile

Follow
Wedgeman7

2,012 Posts.

615

30/11/23

08:14

Post #: 71183556
Share

Originally posted by IronPig: ↑

Hi Odds&Evens, I think you have articulated that well. I really find it hard to see what BP can provide at this stage as far a product development goes. As you pointed out IMU have basically developed a team which are all ex BP that would be equal to what any BP has internally. I am sure that BP will be looking at IMU and the team assembled and thinking that they can add no value to the process at the moment. IMU has an experienced drug development team, the trials are well constructed and delivering the data required, there appears to be a good relationship with the FDA and there is plenty of money in the bank, so what can BP bring to the table. I would say that if BP got involved at this stage it would only slow things down. So in my view commercially for BP there is probably no benefit to have a take over at this stage. It would most likely be more efficient and cost effective if they just let IMU run with it and they pay more at the back end for licensing or a take over. I also think it would be a bit naive of the average punter to think that City of Hope isn’t doing a bit more with the virus if you consider the CF33 progression to OnCARlytics, so what is next? There is plenty of fuel in this bus…so I think it will be an interesting 12 months ahead as well. Look forward to your next post.

Expand

Hi IronPig. I don’t disagree with your thinking with regards takeover and want to ask you if you think someone might do a Roche/Genentech style takeover where IMU is consumed and left as an unlisted wholly owned entity to continue its work as an incubator for big Pharma pipeline? There are a lot of ex Genentech people at IMU thanks in great part to LC and obviously the science.

IMU Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
24 Upvote

0 Great analysis

Reply

Top Stories

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it